A recent Children’s Hospital Los Angeles study led by Principal Investigator Michael Goran, PhD, and Rachel Schenker, MD, a Fellow in the CHLA Liver Transplant Program, has found a novel combination of plasma-based biomarkers that could potentially predict liver fibrosis linked to metabolic dysfunction‐associated steatotic liver disease (MASLD)–the most common pediatric liver disease in the U.S.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
